InVivo Therapeutics Holdings Analysis

InVivo Stock Analysis Notes

The company has price-to-book ratio of 0.1. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. InVivo Therapeutics recorded a loss per share of 3.28. The entity last dividend was issued on the 12th of February 2020. The firm had 1:25 split on the 27th of April 2022. InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries . The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. Invivo Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people. To find out more about InVivo Therapeutics Holdings contact Richard MD at 617 863 5500 or learn more at https://www.invivotherapeutics.com.

InVivo Therapeutics Investment Alerts

InVivo Therapeutics Upcoming and Recent Events

InVivo Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 995.92 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate InVivo Therapeutics's market, we take the total number of its shares issued and multiply it by InVivo Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

InVivo Therapeutics Predictive Daily Indicators

Stock analysis is the technique used by a trader or investor to examine and evaluate how InVivo Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling InVivo shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as InVivo Therapeutics. By using and applying InVivo Stock analysis, traders can create a robust methodology for identifying InVivo entry and exit points for their positions.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.